Thermo Fisher Scientific Inc., the world leader in serving science, today announced the global launch of the Gibco (TM) CTS (TM) Compleo (TM) Fill and Finish System, an automated, functionally closed ...

Management continues to anticipate the presentation of three-year OpRegen trial data in June 2025, with Culley expressing hope it will “provide additional conviction in our approach.” There remains no ...

DUBLIN--(BUSINESS WIRE)--The "Point-of-Care Cell and Gene Therapy Manufacturing Market - A Global and Regional Analysis: Focus on Technology, Therapeutic Area, End User, and Regional Analysis - ...

Technology Adoption Program (TAP) program success demonstrates the ability of Cellares’ IDMO Smart Factory to automate, lower costs and scale out manufacturing for Cabaletta Bio’s clinical-stage CAR T ...

The new Waaree facility will produce PERC and TOPCon cells. Image: Waaree. India cell and module manufacturer Waaree Energies has commissioned a 5.4GW cell manufacturing facility in Gujarat, the ...

The AMT designation gives Cellares’ clients using the Cell Shuttle priority review with the FDA leading to accelerated regulatory filings SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--Cellares, the ...

Chimeric antigen receptor (CAR) T-cell therapy has revolutionized treatment for non-responsive or relapsing hematological malignancies, providing an intensive, personalized form of immunotherapy. It ...

Research appearing in Communications Materials has shown that perovskite solar cells (PSCs) are remarkably resilient to dust ...

CEO Brian Culley highlighted the progress of OpRegen, noting its differentiation from current anti-complement therapies for dry AMD. He emphasized, “OpRegen has shown evidence of both anatomical and ...

Rapid solar manufacturing expansion masks structural gaps, as heavy reliance on imported cells highlights imbalance in ...